Amarin Corporation PLC
Save
194.98M
Market cap
–
Current P/E
500.00x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers.
Similar securities
Based on sector and market capitalization
Report issue